{"id":283,"date":"2015-02-11T17:14:03","date_gmt":"2015-02-11T22:14:03","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=283"},"modified":"2015-02-11T18:38:05","modified_gmt":"2015-02-11T23:38:05","slug":"ipo-pricings-2-11-2015","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-pricings-2-11-2015\/","title":{"rendered":"IPO Pricings 2.11.2015"},"content":{"rendered":"<h1><strong>Thursday Expected Pricings<\/strong><\/h1>\n<p><a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/InovalonHoldings-INOV\" target=\"_blank\">Inovalon Holdings (Nasdaq: INOV) <\/a>&#8211; Inovalon Holdings prices IPO $1.00 above the already upwardly-revised range. &#8216;INOV&#8217; prices 22.2 million shares at $27.00 and will debut on Thursday (2\/12). <a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/InovalonHoldings-INOV\" target=\"_blank\"><br \/>\n<\/a><\/p>\n<p><a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/InvitaeCorporation-NVTA\" target=\"_blank\">Invitae Corporation (NYSE: NVTA) <\/a>&#8211; Invitae Corp. upsized and priced its IPO above the range. &#8216;NVTA priced 6.35 million shares at $16.00 and will debut on Thursday.<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/InvitaeCorporation-NVTA\" target=\"_blank\"><br \/>\n<\/a><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/cgi\/info\/SolWindRenewablePower-SLWD-info.php\" target=\"_blank\">Sol-Wind Renewable Power (NYSE: SLWD)<\/a> &#8211; Postponed<\/p>\n<h2>Rest of Week IPO Schedule<\/h2>\n<p><strong>Friday<\/strong><br \/>\n<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/BellerophonTherapeutics-BLPH\" target=\"_blank\">Bellerophon Therapeutics (Nasdaq: BLPH)<\/a><br \/>\n<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/GreatAjaxCorp-AJX\" target=\"_blank\">Great AJax Corp (NYSE: AJX)<\/a><\/p>\n<p><strong>Day-to-Day<\/strong><br \/>\n<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/Infraredx-REDX\" target=\"_blank\">Infraredx (Nasdaq: REDX)<\/a><br \/>\n<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/InotekPharmaceuticals-ITEK\" target=\"_blank\">Inotek Pharmaceuticals Corporation (Nasdaq: ITEK)<\/a><br \/>\n<a href=\"https:\/\/www.ipoboutique.com\/cgi\/info\/EyegatePharmaceuticalsInc-EYEG-info.php\" target=\"_blank\">Eyegate Pharmaceuticals (Nasdaq: EYEG)<\/a><br \/>\n<a href=\"http:\/\/www.ipoboutique.com\/cgi\/info\/AutoGenomics-AGMX-info.php\" target=\"_blank\">Autogenomics (Nasdaq: AGMX)<\/a><\/p>\n<p><em>IPOBoutique.Com provides comprehensive research, ratings and daily advisories on new issues hitting the IPO market. To subscribe to IPOBoutique\u2019s service: <a href=\"https:\/\/www.ipoboutique.com\/Subscribe.html\" target=\"_blank\">click here. <\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Thursday Expected Pricings Inovalon Holdings (Nasdaq: INOV) &#8211; Inovalon Holdings prices IPO $1.00 above the already upwardly-revised range. &#8216;INOV&#8217; prices 22.2 million shares at $27.00 and will debut on Thursday (2\/12). Invitae Corporation (NYSE: NVTA) &#8211; Invitae Corp. upsized and priced its IPO above the range. &#8216;NVTA priced 6.35 million shares at $16.00 and will[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,22],"tags":[109,110,108],"class_list":["post-283","post","type-post","status-publish","format-standard","hentry","category-ipo","category-ipo-pricing","tag-inov","tag-nvta","tag-slwd"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/283","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=283"}],"version-history":[{"count":7,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/283\/revisions"}],"predecessor-version":[{"id":292,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/283\/revisions\/292"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=283"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=283"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=283"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}